Opaleye Management Inc., 10% Owner at Eton Pharmaceuticals, Inc., sold $935K of ETON
This page documents an SEC Form 4 insider trading disclosure for $ETON securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Opaleye Management Inc. |
|---|---|
| Title | 10% Owner |
| Company | Eton Pharmaceuticals, Inc. |
| Ticker | ETON |
| Transaction Type | Sale |
| Transaction Date | 2026-07-02 |
| Shares Traded | 25,000 |
| Price Per Share | $37.3851 |
| Total Value | $935K |
| Filed Date | 2026-07-07 |
| Accession Number | 0001493152-26-032394 |
Ownership Context
| Shares Owned After Transaction | 60,000 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0001493152-26-032394
Other Insider Trades — ETON
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Krempa David | Chief Business Officer | traded | — | 2026-07-31 |
| Erdogan-Trinkaus Ipek | Chief Commercial Officer | traded | — | 2026-07-31 |
| Matthews Judith M. | Chief Financial Officer | traded | — | 2026-07-31 |
| BRYNJELSEN SEAN | President & CEO, Director | traded | — | 2026-07-31 |
| CASAMENTO CHARLES J | Director | traded | — | 2026-07-31 |
| RIEDEL NORBERT G | Director | traded | — | 2026-07-31 |
| MAIER PAUL V | Director | traded | — | 2026-07-31 |
| Adams Jennifer McKie | Director | traded | — | 2026-07-31 |
| Opaleye Management Inc. | 10% Owner | sold | $563K | 2026-07-14 |
| BRYNJELSEN SEAN | President & CEO, Director | traded | $274K | 2026-07-14 |
Other Trades by Opaleye Management Inc.
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ACOG | Alpha Cognition Inc. | bought | $400K | 2026-08-03 |
| ACOG | Alpha Cognition Inc. | bought | $23K | 2026-07-31 |
| ACOG | Alpha Cognition Inc. | bought | $1K | 2026-07-24 |
| ACOG | Alpha Cognition Inc. | bought | $389K | 2026-07-23 |
| ACOG | Alpha Cognition Inc. | bought | $1.1M | 2026-07-22 |
| ACOG | Alpha Cognition Inc. | bought | $78K | 2026-07-22 |
| SLGL | Sol-Gel Technologies Ltd. | bought | $68K | 2026-07-14 |
| ETON | Eton Pharmaceuticals, Inc. | sold | $563K | 2026-07-14 |
| ETON | Eton Pharmaceuticals, Inc. | sold | $500K | 2026-07-14 |
| ETON | Eton Pharmaceuticals, Inc. | sold | $563K | 2026-07-14 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ETON — Eton Pharmaceuticals, Inc. →
Whisper Score — ETON
Track ETON insider activity in real time on The Wire →
Get alerts when Opaleye Management Inc. files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:10 UTC